A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
Michael S HofmanDeclan G MurphyScott G WilliamsTatenda C NzenzaAlan HerschtalRichard De Abreu LourencoDale L BaileyRay BuddRodney J HicksRoslyn J FrancisNathan L LawrentschukPublished in: BJU international (2018)
This trial will provide data to establish whether PSMA-PET/CT should replace conventional imaging in the primary staging of select high-risk localized PCa, or whether it should be used to provide incremental diagnostic information in selected cases.
Keyphrases
- pet ct
- prostate cancer
- clinical trial
- high resolution
- positron emission tomography
- study protocol
- radical prostatectomy
- phase ii
- randomized controlled trial
- minimally invasive
- phase iii
- early stage
- radiation therapy
- open label
- coronary artery bypass
- locally advanced
- double blind
- machine learning
- squamous cell carcinoma
- lymph node
- health information
- computed tomography
- coronary artery disease
- social media
- photodynamic therapy